What Patients Evaluating AOD 9604 Typically Report Timeline to first changes: Most published protocols note 4 to 6 weeks before body composition changes become measurable Areas of change: Visceral and subcutaneous fat reduction, with particular effect reported in the abdominal region in some subjects Energy and recovery: Some participants in clinical and investigational settings report improved energy and exercise recovery, though this is not a primary mechanism of the peptide What it is not: AOD 9604 does not cause rapid dramatic weight loss the way GLP-1 medications can in the first few months
Discuss all risks and benefits with your doctor, especially if you are pregnant, breastfeeding, or have a history of heart, kidney, or electrolyte disorders
Repose Healthcare offers a fast, accurate, and completely confidential at-home testing service
Full reconstitution guide Advanced calculator Dosing & Reconstitution Guide One combined 12 mg vial educational guide for reconstitution and once-daily total-blend dosing All doses below are stated as total blend (combined AOD-9604 6 mg + CJC-1295 3 mg + Ipamorelin 3 mg)
Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment